support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulletedgrid_view

03/05/2015

CHEPLAPHARM Arzneimittel GmbH launches 100 million EURO investment program
Archive
Read morechevron_right

01/15/2014

CHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.
Archive Press releases
Read morechevron_right

12/31/2012

CHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.
Archive
Read morechevron_right

09/01/2010

CHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®
Archive
Read morechevron_right
Back to topexpand_less